In a 22‑year‑old woman with a history of focal faciobrachial seizures (salivation, nocturnal) since age ten, consistent with benign childhood epilepsy with centrotemporal spikes, normal electroencephalogram and normal neuroimaging, who was recently switched from oxcarbazepine, lacosamide and clobazam to lamotrigine and brivaracetam for future pregnancy safety, what is the appropriate management plan?

Management Plan for Seizure Clusters After Medication Switch

Return to oxcarbazepine-based therapy immediately, as the current lamotrigine and brivaracetam regimen has failed to control seizures and may be worsening them, then optimize preconception planning with high-dose folic acid supplementation.

Immediate Seizure Management

The patient is experiencing breakthrough seizure clusters after switching from a previously effective regimen (oxcarbazepine, lacosamide, clobazam) to lamotrigine and brivaracetam. This represents treatment failure requiring urgent intervention.

Medication Adjustment Strategy

Reintroduce oxcarbazepine as the primary agent 1. The clinical semiology consistent with benign childhood epilepsy with centrotemporal spikes (BCECTS/SeLECTS) typically responds well to oxcarbazepine, with >85% achieving complete or partial control at low doses (75-300 mg/day) 2. Recent evidence shows oxcarbazepine monotherapy achieves 93.83% total effectiveness in SeLECTS 3.

Critical consideration: While lamotrigine can paradoxically worsen seizures in BCECTS 4, and oxcarbazepine has been reported to rarely induce encephalopathy with status epilepticus during sleep (ESES) 5, the patient's previous good response to oxcarbazepine and current deterioration off it strongly favors returning to the original regimen.

Lacosamide as alternative or adjunct: If oxcarbazepine alone proves insufficient, lacosamide monotherapy shows 85.19% cumulative seizure control at 18 months in SeLECTS 3 and ranks highly in pediatric focal epilepsy efficacy 6. The patient previously tolerated lacosamide successfully.

Preconception Optimization

Folic Acid Supplementation - Critical Priority

Initiate 4 mg folic acid daily immediately 7. This high-dose supplementation must begin at least one month before conception and continue through the first trimester 7. This is non-negotiable given the increased neural tube defect risk with antiepileptic drugs, regardless of which specific agent is used.

Medication Safety Profile for Pregnancy

Oxcarbazepine pregnancy considerations 1:

• FDA labeling acknowledges potential fetal harm but does not contraindicate use
• Reduces oral contraceptive effectiveness—counsel on barrier methods or IUD
• Requires shared decision-making balancing seizure control against fetal risk
• Enrollment in North American Antiepileptic Drug (NAAED) Pregnancy Registry recommended (1-888-233-2334)

Lamotrigine is generally considered more pregnancy-compatible than many antiepileptics 7, but in this patient it has failed to control seizures, making it inappropriate regardless of pregnancy safety profile. Uncontrolled seizures pose greater maternal-fetal risk than medication exposure 7.

Key principle: Achieving seizure freedom before conception is paramount 7. Approximately one-third of women with seizure disorders experience increased seizure frequency during pregnancy 7. Uncontrolled epilepsy increases risks of miscarriage, low birth weight, developmental disabilities, and hemorrhagic disease of the newborn 7.

Specific Monitoring Requirements

• Sodium levels: Check baseline and periodically, as oxcarbazepine can cause hyponatremia 1
• HLA-B*15:02 screening: If not previously done, test before oxcarbazepine initiation to reduce Stevens-Johnson syndrome risk in Han Chinese populations 2
• Thyroid function: Ensure optimization if any thyroid disorder present 7
• Reproductive endocrine screening: Given epilepsy association with PCOS and menstrual disorders 8, assess menstrual regularity, weight, hirsutism

Contraception Until Seizure Control Achieved

Do not attempt pregnancy until seizure-free for at least 3-6 months on optimized medication regimen. Use highly effective contraception that is not affected by enzyme-inducing antiepileptics:

• Preferred: Levonorgestrel IUD or copper IUD (not affected by drug interactions)
• Avoid: Combined oral contraceptives with oxcarbazepine (reduced efficacy) 1
• Alternative: Depot medroxyprogesterone or barrier methods

Psychosocial Support

Address anxiety about seizure clusters and pregnancy planning. Educate that:

• BCECTS/SeLECTS typically has excellent long-term prognosis with tendency toward natural remission 2
• Achieving seizure control before pregnancy dramatically improves outcomes
• With proper management, women with epilepsy have successful pregnancies

Timeline for Pregnancy Planning

1. Immediate (Week 1-2): Restart oxcarbazepine, initiate 4 mg folic acid daily, ensure effective contraception
2. Month 1-3: Titrate to seizure control, monitor sodium levels, confirm seizure freedom
3. Month 3-6: Maintain seizure freedom, continue folic acid, optimize any comorbidities
4. Month 6+: If seizure-free, consider pregnancy attempt with close neurologic and obstetric monitoring

Common pitfall to avoid: Do not prioritize theoretical medication teratogenicity over achieving seizure control. The evidence clearly shows that uncontrolled maternal seizures pose greater fetal risk than most antiepileptic medications 7.